108 related articles for article (PubMed ID: 27568664)
1. Tumour cell membrane laminin expression is associated with basal-like phenotype and poor survival in Nigerian breast cancer.
Agboola AO; Ebili HO; Iyawe VO; Banjo AA; Salami BS; Rakha EA; Nolan C; Ellis IO; Green AR
Malays J Pathol; 2016 Aug; 38(2):83-92. PubMed ID: 27568664
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women.
Agboola AO; Musa AA; Ayoade BA; Banjo AA; Anunobi CC; Deji-Agboola AM; Rakha EA; Nolan C; Ellis IO; Green AR
Pathol Res Pract; 2014 Jan; 210(1):10-7. PubMed ID: 24176171
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart.
Agboola AO; Banjo AA; Anunobi CC; Ayoade BA; Deji-Agboola AM; Musa AA; Abdel-Fatah T; Nolan CC; Rakha EA; Ellis IO; Green AR
Malays J Pathol; 2014 Apr; 36(1):3-17. PubMed ID: 24763230
[TBL] [Abstract][Full Text] [Related]
4. PIASγ expression in relation to clinicopathological, tumour factors and survival in indigenous black breast cancer women.
Agboola A; Musa A; Banjo A; Ayoade B; Deji-Agboola M; Nolan C; Rakha E; Ellis I; Green A
J Clin Pathol; 2014 Apr; 67(4):301-6. PubMed ID: 24170211
[TBL] [Abstract][Full Text] [Related]
5. Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women.
Agboola AJ; Musa AA; Wanangwa N; Abdel-Fatah T; Nolan CC; Ayoade BA; Oyebadejo TY; Banjo AA; Deji-Agboola AM; Rakha EA; Green AR; Ellis IO
Breast Cancer Res Treat; 2012 Sep; 135(2):555-69. PubMed ID: 22842985
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and molecular characteristics of Ku 70/80 expression in Nigerian breast cancer and its potential therapeutic implications.
Agboola AO; Ebili HO; Iyawe VO; Banjo AA; Salami BA; Rakha EA; Nolan CC; Ellis IO; Green AR
Pathol Res Pract; 2017 Jan; 213(1):27-33. PubMed ID: 27914769
[TBL] [Abstract][Full Text] [Related]
7. Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women.
Agboola AO; Banjo AA; Anunobi CC; Salami B; Agboola MD; Musa AA; Nolan CC; Rakha EA; Ellis IO; Green AR
ISRN Oncol; 2013; 2013():675051. PubMed ID: 23691362
[TBL] [Abstract][Full Text] [Related]
8. Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women.
Esnakula AK; Ricks-Santi L; Kwagyan J; Kanaan YM; DeWitty RL; Wilson LL; Gold B; Frederick WA; Naab TJ
J Clin Pathol; 2014 Feb; 67(2):153-60. PubMed ID: 23986556
[TBL] [Abstract][Full Text] [Related]
9. Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients.
Ebili HO; Iyawe VO; Adeleke KR; Salami BA; Banjo AA; Nolan C; Rakha E; Ellis I; Green A; Agboola AOJ
Mol Diagn Ther; 2018 Feb; 22(1):79-90. PubMed ID: 29075961
[TBL] [Abstract][Full Text] [Related]
10. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.
Rodríguez-Pinilla SM; Sarrió D; Honrado E; Moreno-Bueno G; Hardisson D; Calero F; Benítez J; Palacios J
J Clin Pathol; 2007 Sep; 60(9):1006-12. PubMed ID: 17105822
[TBL] [Abstract][Full Text] [Related]
11. Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes.
Niwińska A; Olszewski W; Murawska M; Pogoda K
J Neurooncol; 2011 Dec; 105(3):547-53. PubMed ID: 21656328
[TBL] [Abstract][Full Text] [Related]
12. CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma.
Czapiewski P; Wełnicka-Jaśkiewicz M; Seroczyńska B; Skokowski J; Sejda A; Szade J; Wiewiora C; Biernat W; Żaczek A
Pol J Pathol; 2015 Sep; 66(3):269-75. PubMed ID: 26619106
[TBL] [Abstract][Full Text] [Related]
13. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
Thike AA; Tan PH; Ikeda M; Iqbal J
Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
15. Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer.
Baker BG; Ball GR; Rakha EA; Nolan CC; Caldas C; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 Jan; 137(1):127-37. PubMed ID: 23208589
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.
Ahmed SS; Thike AA; Zhang K; Lim JC; Tan PH
J Clin Pathol; 2017 Apr; 70(4):320-326. PubMed ID: 27612503
[TBL] [Abstract][Full Text] [Related]
17. Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.
Tan DS; Marchió C; Jones RL; Savage K; Smith IE; Dowsett M; Reis-Filho JS
Breast Cancer Res Treat; 2008 Sep; 111(1):27-44. PubMed ID: 17922188
[TBL] [Abstract][Full Text] [Related]
18. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
19. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
Zhang H; Rakha EA; Ball GR; Spiteri I; Aleskandarany M; Paish EC; Powe DG; Macmillan RD; Caldas C; Ellis IO; Green AR
Breast Cancer Res Treat; 2010 May; 121(1):41-51. PubMed ID: 19590950
[TBL] [Abstract][Full Text] [Related]
20. Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.
Asleh K; Won JR; Gao D; Voduc KD; Nielsen TO
Breast Cancer Res Treat; 2018 Feb; 168(1):107-115. PubMed ID: 29159761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
